Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study.

Strilciuc, Stefan; Radu, Constantin; Grad, Diana-Alecsandra; Stan, Adina Dora; Vladescu, Cristian; Buzoianu, Anca Dana; Muresanu, Dafin

Strilciuc, Stefan; Radu, Constantin; Grad, Diana-Alecsandra; Stan, Adina Dora; Vladescu, Cristian; Buzoianu, Anca Dana; Muresanu, Dafin.

Afiliação

Strilciuc S; Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Radu C; RoNeuro Institute for Neurological Research and Diagnostic, 400364 Cluj-Napoca, Romania.
Grad DA; Department of Public Health, Faculty of Political, Administrative and Communication Sciences, Babes-Bolyai University, 400084 Cluj-Napoca, Romania.
Stan AD; Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Vladescu C; RoNeuro Institute for Neurological Research and Diagnostic, 400364 Cluj-Napoca, Romania.
Buzoianu AD; Department of Public Health, Faculty of Political, Administrative and Communication Sciences, Babes-Bolyai University, 400084 Cluj-Napoca, Romania.
Muresanu D; Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Healthcare (Basel) ; 11(10)2023 May 21.

Article em En | MEDLINE | ID: mdl-37239783

Palavras-chave

cerebrolysin; cost-effectiveness; stroke

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Avaliacao_economica / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Healthcare (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Romênia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google